In a clinical study by Xu et al., treatment with umbilical cord-derived MSCs led to a decline in serum levels of anti-SSA/Ro and anti-SSB/La antibodies in 24 SS patients [134]. This evidence concerns the gene CALR and synovial sarcoma.